185 related articles for article (PubMed ID: 24333618)
1. Warfarin, calciphylaxis, atrial fibrillation, and patients on dialysis: outlier subsets and practice guidelines.
Eiser AR
Am J Med; 2014 Apr; 127(4):253-4. PubMed ID: 24333618
[No Abstract] [Full Text] [Related]
2. Oral Anticoagulation in End-Stage Renal Disease: Is It Time to Absolve Warfarin?
Genovesi S
Am J Nephrol; 2016; 44(4):255-257. PubMed ID: 27598337
[No Abstract] [Full Text] [Related]
3. Warfarin and stroke outcomes in hemodialysis patients with atrial fibrillation.
Genovesi S; Santoro A
J Am Soc Nephrol; 2009 Oct; 20(10):2090-2. PubMed ID: 19713302
[No Abstract] [Full Text] [Related]
4. Warfarin in haemodialysis patients with atrial fibrillation: what benefit?
Yang F; Chou D; Schweitzer P; Hanon S
Europace; 2010 Dec; 12(12):1666-72. PubMed ID: 21045011
[TBL] [Abstract][Full Text] [Related]
5. Calciphylaxis in end-stage renal disease patients.
Verdalles U; García de Vinuesa S; Luño J
Nephrol Dial Transplant; 2012 Sep; 27(9):3663; author reply 3663-4. PubMed ID: 22805222
[No Abstract] [Full Text] [Related]
6. Anticoagulants in patients with atrial fibrillation and end-stage renal disease.
Brimble KS; Ingram AJ; Eikelboom JW; Hart RG
Postgrad Med; 2012 Nov; 124(6):17-25. PubMed ID: 23322135
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of Warfarin in Dialysis Patients With Atrial Fibrillation: A Meta-Analysis of Observational Studies.
Liu G; Long M; Hu X; Hu CH; Liao XX; Du ZM; Dong YG
Medicine (Baltimore); 2015 Dec; 94(50):e2233. PubMed ID: 26683937
[TBL] [Abstract][Full Text] [Related]
8. [Left atrial appendage occlusion as replacement of coumarin anticoagulants in calciphylaxis].
Andolfatto M; Tangredi M; Vischi M; Pinerolo C; Cereda A; Napodano P; Cozzolino M
G Ital Nefrol; 2022 Jun; 39(3):. PubMed ID: 35819038
[TBL] [Abstract][Full Text] [Related]
9. A case-control study of calciphylaxis in Japanese end-stage renal disease patients.
Hayashi M; Takamatsu I; Kanno Y; Yoshida T; Abe T; Sato Y;
Nephrol Dial Transplant; 2012 Apr; 27(4):1580-4. PubMed ID: 22121234
[TBL] [Abstract][Full Text] [Related]
10. [New international guidelines on antithrombotic therapy in atrial fibrillation].
Tveit A
Tidsskr Nor Laegeforen; 2009 Jun; 129(13):1332-5. PubMed ID: 19561659
[TBL] [Abstract][Full Text] [Related]
11. Closing in on ending the warfarin era for stroke prevention in nonvalvular atrial fibrillation.
Turi ZG
Catheter Cardiovasc Interv; 2009 Aug; 74(2):223-4. PubMed ID: 19642149
[No Abstract] [Full Text] [Related]
12. Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm.
Chaudhari D; Bhuriya R; Arora R
Am J Ther; 2011 Jan; 18(1):e1-e11. PubMed ID: 20460986
[TBL] [Abstract][Full Text] [Related]
13. The intersection of risk and benefit: is warfarin anticoagulation suitable for atrial fibrillation in patients on hemodialysis?
Sood MM; Komenda P; Sood AR; Rigatto C; Bueti J
Chest; 2009 Oct; 136(4):1128-1133. PubMed ID: 19809054
[TBL] [Abstract][Full Text] [Related]
14. New oral anticoagulants in elderly patients with atrial fibrillation.
Deedwania PC
Am J Med; 2013 Apr; 126(4):289-96. PubMed ID: 23369212
[TBL] [Abstract][Full Text] [Related]
15. Barriers to anticoagulation in patients with atrial fibrillation: changing physician-related factors.
Lane DA; Lip GY
Stroke; 2008 Jan; 39(1):7-9. PubMed ID: 18048849
[No Abstract] [Full Text] [Related]
16. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
Mant JW
Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
[No Abstract] [Full Text] [Related]
17. Coumarin use in dialysis patients with atrial [corrected] fibrillation: yes, after individual risk stratification.
Hörl WH
Nephrol Dial Transplant; 2009 Nov; 24(11):3285-7. PubMed ID: 19666666
[No Abstract] [Full Text] [Related]
18. [Warfarin should not be recommended to anyone with atrial fibrillation].
Samuelsson O; Saeed A
Lakartidningen; 2017 May; 114():. PubMed ID: 28510240
[No Abstract] [Full Text] [Related]
19. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Introduction.
Palevsky PM
Clin J Am Soc Nephrol; 2016 Nov; 11(11):2078. PubMed ID: 27821638
[No Abstract] [Full Text] [Related]
20. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
